摘要 |
Inflammation caused by disease states such as rheumatism, gout, neurodegeneration and tumours result in the increased effectiveness of the opioid peptide biphalin or its analogues, due likely to the increased permeability of the "blood-brain barrier", due to which it becomes possible to use the opioid peptide to produce a new analgesic for use during inflammation caused by rheumatism, gout, neurodegeneration, post-surgical or post-accidental trauma or tumours. |
申请人 |
LIPKOWSKI, ANDRZEJ, W.;CARR, DANIEL;MISICKA-KESIK, ALEKSANDRA;KOSSON, PIOTR;KLINOWIECKA, ANNA |
发明人 |
LIPKOWSKI, ANDRZEJ, W.;CARR, DANIEL;MISICKA-KESIK, ALEKSANDRA;KOSSON, PIOTR;KLINOWIECKA, ANNA |